Form 8-K - Current report:
SEC Accession No. 0001104659-25-019145
Filing Date
2025-02-28
Accepted
2025-02-28 16:10:21
Documents
13
Period of Report
2025-02-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm257938d1_8k.htm   iXBRL 8-K 29654
  Complete submission text file 0001104659-25-019145.txt   205721

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ipsc-20250226.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipsc-20250226_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipsc-20250226_pre.xml EX-101.PRE 22361
15 EXTRACTED XBRL INSTANCE DOCUMENT tm257938d1_8k_htm.xml XML 3812
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

EIN.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40498 | Film No.: 25690221
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)